TABLE 6.

Results of testing age and formulation effects on the composite acceptability endpoint (p-values are provided).

Comparison	Age	Formulation	Interaction age-by-formulation
Mini-tablets vs. syrup	0.5985	<0.0001	0.2256
Mini-tablets vs. round tablet	Not interpretable	Not interpretable	0.0863
Mini-tablets vs. oblong tablet	Not interpretable	Not interpretable	0.0007
Round tablet vs. syrup	0.3325	0.0050	0.6580
Oblong tablet vs. syrup	0.0242	<0.0001	0.7331
Oblong tablet vs. round tablet	Not interpretable	Not interpretable	0.0300

In case of a significant age-by-formulation interaction (p < 0.1) overall age and overall formulation results are not interpretable